Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has lifted the ...

Vanda Pharmaceuticals (VNDA) announced that the FDA has lifted the partial clinical hold on protocol VP-VLY-686-3403, which until today limited the protocol to a maximum of 90 doses of tradipitant.

BELMONT PARK, N.Y., Oct. 8, 2025 /PRNewswire/ -- The New York Islanders today announced a multi-year agreement with Vanda Pharmaceuticals, a global biopharmaceutical company, naming them the team's ...

Vanda ( ($VNDA) ) has shared an update. On December 4, 2025, Vanda Pharmaceuticals announced that the FDA has lifted the partial clinical hold on ...

Vanda Pharmaceuticals, a company that develops medicines for conditions with limited to no treatment options, has signed a multi-year partnership with the New York Islanders to become their jersey ...

Vanda Pharmaceuticals said the Food and Drug Administration has lifted the partial clinical hold on its motion sickness drug tradipitant . The decision allows the Washington, D.C., company to extend ...

WASHINGTON, Aug. 18, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it secured a landmark victory over the U.S. Food and Drug Administration (FDA) in its ...

Investing.com -- Vanda Pharmaceuticals (NASDAQ:VNDA) stock rose 11% in after-hours trading on Thursday after the company announced that the U.S. Food and Drug Administration (FDA) has lifted a partial ...

Tradipitant could become the first new pharmacologic treatment for motion sickness in over 40 years.

WASHINGTON, Dec. 4, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has accepted the filing of Vanda's New Drug ...

In celebration of Singapore’s 57th birthday, Vanda Patisserie will be launching their “Don’t Say Bo Jio” Madeleines Box (S$28), containing six madeleines in the flavours of nostalgic Singaporean ...